Intrinsiqq
Soleno Therapeutics Inc logo

Soleno Therapeutics Inc

SLNO

Compare

Profitability & Returns

Revenue (FY)

$190M

Net Income (TTM)

$96M

▲ +111.9% YoY

Op. Margin

4.94%

ROIC

14.43%

▲ +66.9pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

$105M

▲ +167.4% YoY

Op. Cash Flow (TTM)

$106M

▲ +167.7% YoY

Net Debt

-$201M

Net Cash Position

Cash & Equiv.

$256M

Continue Research

SourceComputed from the 10-Q filed 30 Apr 2026, covering the period ending 31 Mar 2026, as reported to the SEC. Data last refreshed 3 Sept 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.

Peers

Pharmaceutical Preparations · Pick stocks to compare with SLNO

CompareIntrinsic value
URGNUrogen Pharma Ltd.
$24.75-3.81%30
CYRXCryoport Inc.
$19.10+19.00%13
AMRNAmarin Corp PLC\Uk
$11.61+0.26%46
MGNXMacrogenics Inc.
$2.33+4.95%36
LFVNLifeVantage Corporation
$5.22+3.37%75
ABUSArbutus Biopharma Corporation
$3.66-0.41%60
MRVIMaravai Lifesciences Holdings Inc.
$7.52+7.74%10
VNDAVanda Pharmaceuticals Inc.
$3.82+6.41%10

Spot a number that looks wrong? Check it in SLNO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing SLNO

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.